30 articles, transcripts, and reports
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company’s performance has improved to pre-crisis levels…
AbbVie Inc. (NYSE: ABBV) Q3 2020 earnings call dated Oct. 30, 2020 Corporate Participants: Liz Shea — Investor Relations Richard A. Gonzalez — Chairman of the Board and Chief…
AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26% increase in total revenue to…
AbbVie (NYSE: ABBV), which completed the acquisition of Allergan on May 8, 2020, reported second quarter 2020 earnings results today. The company’s adjusted earnings and…
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results last Friday. The…
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea — Vice President, Investor Relations Richard A. Gonzalez — Chairman of the Board and…
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea — Vice President of Investor Relations Richard A. Gonzalez — Chairman of the Board…
For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was declared a pandemic by the…
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The…
AbbVie Inc. (NYSE: ABBV) reported a 31% dip in earnings for the third quarter of 2019 due to higher costs and expenses. However, the results…
